Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts
暂无分享,去创建一个
Yi Liu | Xiaolu Hou | Bing Song | Weiming Tian | Xiongbiao Chen | Xiongbiao Chen | B. Song | X. Hou | Shupei Qiao | W. Tian | Qingyuan Meng | Rui Fang | Shupei Qiao | Qingyuan Meng | R. Fang | Yi Liu | Weiming Tian | Rui Fang | Xiaolu Hou
[1] Q. Li,et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.
[2] Kevin Bersell,et al. Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury , 2009, Cell.
[3] A. Mehta,et al. Critical path in cardiac stem cell therapy: an update on cell delivery. , 2013, Cytotherapy.
[4] Joel Stein,et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[5] Hai-bin Wang,et al. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. , 2014, Biomaterials.
[6] J. Kreuter,et al. Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake. , 2000, Journal of microencapsulation.
[7] Xiongbiao Chen,et al. Self-cross-linkable hydrogels composed of partially oxidized alginate and gelatin for myocardial infarction repair , 2013 .
[8] Randy L. Johnson,et al. Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size , 2011, Science.
[9] M. Forouzanfar,et al. Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010. , 2012, Global heart.
[10] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[11] Pieter A. Doevendans,et al. Sustained Delivery of Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Stimulates Endogenous Cardiac Repair in the Chronic Infarcted Pig Heart , 2014, Journal of Cardiovascular Translational Research.
[12] Shay Artzi,et al. In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging , 2011, Nature materials.
[13] J. C. Belmonte,et al. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation , 2010, Nature.
[14] L. Kirshenbaum,et al. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy. , 2010, Cellular signalling.
[15] L. Powell-Braxton,et al. Effects of Igf1 gene deletion on postnatal growth patterns. , 1999, Endocrinology.
[16] Y. Maejima,et al. Myocardial Injection With GSK-3&bgr;–Overexpressing Bone Marrow–Derived Mesenchymal Stem Cells Attenuates Cardiac Dysfunction After Myocardial Infarction , 2011, Circulation research.
[17] T. Crombleholme,et al. Adenoviral-mediated gene transfer of insulin-like growth factor 1 enhances wound healing and induces angiogenesis. , 2014, The Journal of surgical research.
[18] P. Goichberg,et al. Cardiac stem cell niches. , 2014, Stem cell research.
[19] M. Keating,et al. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. , 2006, Chemistry & biology.
[20] M. Ushio-Fukai,et al. Low‐Dose 6‐Bromoindirubin‐3′‐oxime Induces Partial Dedifferentiation of Endothelial Cells to Promote Increased Neovascularization , 2014, Stem cells.
[21] Liju Yang,et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.
[22] Leah B. Honor,et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy , 2012, Proceedings of the National Academy of Sciences.
[23] W. Rottbauer,et al. Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial , 2013, Clinical Research in Cardiology.
[24] Roberto Bolli,et al. Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions , 2013, Circulation research.
[25] E. Marbán,et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. , 2011, Journal of the American College of Cardiology.
[26] G. Allmaier,et al. Characterization of cross‐linked gelatin nanoparticles by electrophoretic techniques in the liquid and the gas phase , 2013, Electrophoresis.
[27] John McAnally,et al. Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size , 2011, Science Signaling.
[28] P. Greengard,et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.
[29] J. Leor,et al. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. , 2011, Biomaterials.
[30] Z. Ungvari,et al. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[31] Zu-wei Ma,et al. Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy. , 2014, Biomacromolecules.
[32] D. Torella,et al. Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart , 2014, Nature Protocols.
[33] Yen Chang,et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. , 2008, Cardiovascular research.
[34] Joong Kon Park,et al. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation , 2011, Bioprocess and Biosystems Engineering.
[35] P. Anversa,et al. Mechanisms of myocardial regeneration. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[36] A. Sinusas,et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. , 2010, Journal of molecular and cellular cardiology.
[37] Mark A Sussman,et al. Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.
[38] J. Boehm,et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.
[39] R. Löbenberg,et al. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.